Reinsurance Agreement

A reinsurance agreement is a contract between an insurance company and a reinsurer that transfers some of the risk of loss from the insurer to the reinsurer. The reinsurer agrees to pay the insurer for a portion of the losses the insurer incurs in exchange for a premium. Here are some key features of a reinsurance agreement:

  • Purpose: The purpose of a reinsurance agreement is to reduce the risk of loss to the insurer by transferring some of the risk to the reinsurer.

  • Types: There are different types of reinsurance agreements, such as facultative reinsurance (a case-by-case basis) or treaty reinsurance (a standing agreement for a set period).

  • Proportional or Non-proportional: Reinsurance can be proportional (where the reinsurer shares a portion of each policy) or non-proportional (where the reinsurer covers losses above a certain amount).

  • Terms: The terms of a reinsurance agreement include the premium, the types of losses covered, the maximum amount of coverage, and the duration of the agreement.

  • Benefits: The benefits of a reinsurance agreement include reducing the insurer's risk of loss, improving the insurer's financial stability, and allowing the insurer to underwrite larger policies than it could without reinsurance.

  • Risks: The risks associated with a reinsurance agreement include the reinsurer's financial strength, the potential for disputes over coverage, and the potential for moral hazard (where the insurer takes more risk because it knows it is partially protected by the reinsurer).

Example:

An insurance company writes a policy with a liability limit of $10 million for a construction project. The insurer enters into a reinsurance agreement with a reinsurer that covers losses above $5 million. The insurer pays a premium to the reinsurer for this coverage, and the reinsurer agrees to pay the insurer for any losses above $5 million. If the insurer incurs a loss of $8 million on the policy, the reinsurer would pay $3 million to the insurer, reducing the insurer's net loss to $5 million.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.